Kechuang Biomedical ETF (588250) rose 1.51%, with a turnover of 29.5087 million yuan
DATE:  Apr 11 2025

On April 11, Penghua SSE Science and Technology Innovation Board Biomedical ETF (588250) closed up 1.51%, with a turnover of 29.5087 million yuan.

Kechuang Biomedical ETF (588250) was established on March 12, 2025, and the full name of the fund is Penghua SSE Science and Technology Innovation Board Biomedical Exchange-traded Open-ended Index Securities Investment Fund, and the fund is referred to as Penghua SSE Science and Technology Innovation Board Biomedical ETF. The fund has a management fee of 0.50% per annum and a custody fee of 0.10% per annum. The performance of the STAR Biomedical ETF (588250) is based on the return rate of the SSE STAR Market Biomedical Index.

In terms of scale, as of April 10, the latest share of Kechuang Biomedical ETF (588250) was 260 million shares, and the latest scale was 258 million yuan.

The current fund manager of Kechuang Biomedical ETF (588250) is Lin Song. Lin Song has managed (or intends to manage) the fund since March 12, 2025, with a return of -0.56% during his tenure.

According to the latest regular report, the heavy stocks of the Science and Technology Innovation Biomedical ETF (588250) include United Imaging Healthcare, BeiGene, Huitai Medical, MGI, Zelgen Pharmaceutical, Allist, Baili Tianheng, Junshi Biosciences, Borui Pharmaceutical, and Aibo Medical, with the following proportions.

, , ,
stock symbolstock nameposition ratio, number of shares held (shares).Market value of the position (RMB).
688271 United Imaging Healthcare 0.49% 21,902,865,600
688235 BeiGene 0.33% 8800.001,897,100
688617 Huitai Medical 0.28% 4500.001.6407 million
688114 MGI 0.24% 15,91.4248 million
688266 Zelgen Pharmaceutical: 0.22%, 14,1128.45 million
688578 Allist, 0.22%, 17,201,265,900
688506 Baili Tianheng 0.22% 6100.001.2933 million
688180 Junshi Biosciences 0.21% 4091.1996 million
688166 Borui Pharmaceutical: 0.17%, 22,600, 975,600
688050, Aibo Medical, 0.16%, 10,100, 955,900

Risk Warning: The market is risky, and investment needs to be cautious. This article is automatically released by the AI model, and any information appearing in this article (including but not limited to individual stocks, comments, forecasts, charts, indicators, theories, any form of expression, etc.) is for reference only and does not constitute personal investment advice. The MACD golden cross signal is formed, and these stocks are rising well!

Follow Yicai Global on

star50stocks

Ticker Name

Percentage Change

Inclusion Date